Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia.
Biomarker
CPT1
Diet
Fatty acid oxidation
Glycogen storage disease
Monitoring
Journal
Genes & nutrition
ISSN: 1555-8932
Titre abrégé: Genes Nutr
Pays: Germany
ID NLM: 101280108
Informations de publication
Date de publication:
06 Jun 2023
06 Jun 2023
Historique:
received:
21
09
2022
accepted:
05
05
2023
medline:
7
6
2023
pubmed:
7
6
2023
entrez:
6
6
2023
Statut:
epublish
Résumé
Glycogen storage disease type Ia (GSDIa) is an inborn metabolic disorder caused by the deficiency of glucose-6-phospatase-α (G6Pase-α) leading to mitochondrial dysfunction. It remains unclear whether mitochondrial dysfunction is present in patients' peripheral blood mononuclear cells (PBMC) and whether dietary treatment can play a role. The aim of this study was to investigate mitochondrial function in PBMC of GSDIa patients. Ten GSDIa patients and 10 age-, sex- and fasting-time matched controls were enrolled. Expression of genes involved in mitochondrial function and activity of key fatty acid oxidation (FAO) and Krebs cycle proteins were assessed in PBMC. Targeted metabolomics and assessment of metabolic control markers were also performed. Adult GSDIa patients showed increased CPT1A, SDHB, TFAM, mTOR expression (p < 0.05) and increased VLCAD, CPT2 and citrate synthase activity in PBMC (p < 0.05). VLCAD activity directly correlated with WC (p < 0.01), BMI (p < 0.05), serum malonycarnitine levels (p < 0.05). CPT2 activity directly correlated with BMI (p < 0.05). Mitochondrial reprogramming is detectable in PBMC of GSDIa patients. This feature may develop as an adaptation to the liver enzyme defect and may be triggered by dietary (over)treatment in the frame of G6Pase-α deficiency. PBMC can represent an adequate mean to assess (diet-induced) metabolic disturbances in GSDIa.
Sections du résumé
BACKGROUND
BACKGROUND
Glycogen storage disease type Ia (GSDIa) is an inborn metabolic disorder caused by the deficiency of glucose-6-phospatase-α (G6Pase-α) leading to mitochondrial dysfunction. It remains unclear whether mitochondrial dysfunction is present in patients' peripheral blood mononuclear cells (PBMC) and whether dietary treatment can play a role. The aim of this study was to investigate mitochondrial function in PBMC of GSDIa patients.
METHODS
METHODS
Ten GSDIa patients and 10 age-, sex- and fasting-time matched controls were enrolled. Expression of genes involved in mitochondrial function and activity of key fatty acid oxidation (FAO) and Krebs cycle proteins were assessed in PBMC. Targeted metabolomics and assessment of metabolic control markers were also performed.
RESULTS
RESULTS
Adult GSDIa patients showed increased CPT1A, SDHB, TFAM, mTOR expression (p < 0.05) and increased VLCAD, CPT2 and citrate synthase activity in PBMC (p < 0.05). VLCAD activity directly correlated with WC (p < 0.01), BMI (p < 0.05), serum malonycarnitine levels (p < 0.05). CPT2 activity directly correlated with BMI (p < 0.05).
CONCLUSION
CONCLUSIONS
Mitochondrial reprogramming is detectable in PBMC of GSDIa patients. This feature may develop as an adaptation to the liver enzyme defect and may be triggered by dietary (over)treatment in the frame of G6Pase-α deficiency. PBMC can represent an adequate mean to assess (diet-induced) metabolic disturbances in GSDIa.
Identifiants
pubmed: 37280548
doi: 10.1186/s12263-023-00729-y
pii: 10.1186/s12263-023-00729-y
pmc: PMC10245432
doi:
Types de publication
Journal Article
Langues
eng
Pagination
10Informations de copyright
© 2023. The Author(s).
Références
Pathol Res Pract. 1980 May;167(1):136-50
pubmed: 6935637
Obesity (Silver Spring). 2010 Sep;18(9):1695-700
pubmed: 20111019
Food Nutr Res. 2016 Nov 23;60:33554
pubmed: 27885970
J Proteome Res. 2019 Jul 5;18(7):2965-2978
pubmed: 31173686
Ann Nutr Metab. 2010;56(3):225-32
pubmed: 20357432
Mol Nutr Food Res. 2012 Jul;56(7):1160-72
pubmed: 22610960
Br J Nutr. 2016 Sep;116(6):1022-32
pubmed: 27501771
Cell Metab. 2012 Dec 5;16(6):765-76
pubmed: 23168219
Hepatology. 2021 Nov;74(5):2491-2507
pubmed: 34157136
Front Endocrinol (Lausanne). 2020 Nov 23;11:579981
pubmed: 33329388
Hum Mol Genet. 2020 Jan 15;29(2):286-294
pubmed: 31816064
Clin Exp Med. 2017 Aug;17(3):305-323
pubmed: 27613073
Orphanet J Rare Dis. 2015 Jul 29;10:91
pubmed: 26219379
Exp Biol Med (Maywood). 2020 Aug;245(14):1268-1279
pubmed: 32436749
EMBO Rep. 2013 Mar 1;14(3):242-51
pubmed: 23399656
Mol Biosyst. 2015 Jun;11(6):1525-35
pubmed: 25689098
Annu Rev Physiol. 2016;78:23-44
pubmed: 26474213
Int J Mol Sci. 2018 Jul 13;19(7):
pubmed: 30011848
Vestn Ross Akad Med Nauk. 2014;(7-8):78-84
pubmed: 25563007
Nutrients. 2021 Oct 27;13(11):
pubmed: 34836082
Genet Med. 2014 Nov;16(11):e1
pubmed: 25356975
Biol Res. 2019 Aug 19;52(1):44
pubmed: 31426858
Diabetes. 2019 Aug;68(8):1552-1564
pubmed: 31088855
Sci Rep. 2021 Sep 15;11(1):18329
pubmed: 34526523
J Inherit Metab Dis. 2019 Sep;42(5):850-856
pubmed: 30957255
Cell Metab. 2019 Sep 3;30(3):447-461.e5
pubmed: 31378464
Hum Mol Genet. 2020 Mar 27;29(5):834-844
pubmed: 31961433
Hum Mutat. 2008 Jul;29(7):921-30
pubmed: 18449899
Eur J Pediatr. 2002 Oct;161 Suppl 1:S112-9
pubmed: 12373584
J Inherit Metab Dis. 2018 Nov;41(6):1169-1178
pubmed: 30194637
J Biol Chem. 2003 Dec 12;278(50):50428-34
pubmed: 14517221
Eur J Pediatr. 2002 Oct;161 Suppl 1:S65-9
pubmed: 12373575
Int J Mol Sci. 2020 Jun 12;21(12):
pubmed: 32545699
Mol Metab. 2018 Oct;16:100-115
pubmed: 30100243
Orphanet J Rare Dis. 2019 Nov 15;14(1):261
pubmed: 31730495
Cell Cycle. 2011 Mar 15;10(6):861-2
pubmed: 21325894
Hum Mol Genet. 2004 May 1;13(9):935-44
pubmed: 15016765
Sci Rep. 2017 Mar 20;7:44408
pubmed: 28317891
Curr Diab Rep. 2015 Jul;15(7):40
pubmed: 25957525
PLoS One. 2012;7(9):e45429
pubmed: 23024820
Orphanet J Rare Dis. 2020 Apr 19;15(1):99
pubmed: 32306986
J Inherit Metab Dis. 2018 Nov;41(6):985-995
pubmed: 29435782
Hum Mol Genet. 2022 Mar 21;31(6):914-928
pubmed: 34617103
PLoS Comput Biol. 2013;9(8):e1003186
pubmed: 23966849
PLoS One. 2015 Mar 30;10(3):e0119687
pubmed: 25822152
J Inherit Metab Dis. 2021 Jul;44(4):916-925
pubmed: 33580884
Hum Mol Genet. 2019 Jan 1;28(1):143-154
pubmed: 30256948